C3 reveals FDA approval delays

Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, has deferred the date it expects to win approval from the US Food and Drug Administration to the fourth calendar quarter of 2007, or even to early next year.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byNorth Metro TAFE


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
51 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer